We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

HL Select UK Growth Shares - March review

HL SELECT UK GROWTH SHARES

HL Select UK Growth Shares - March review

Monthly roundup

Important information - The value of this fund can still fall so you could get back less than you invested, especially over the short term. The information shown is not personal advice and the information about individual companies represents our view as managers of the fund. It is not a personal recommendation to invest in a particular company. If you are at all unsure of the suitability of an investment for your circumstances please contact us for personal advice. The HL Select Funds are managed by our sister company HL Fund Managers Ltd.
Charlie Huggins

Charlie Huggins (CFA) - Fund Manager

6 April 2018

Global equity markets came under pressure in March as trade tensions between the US and China intensified and US technology stocks sold off sharply.

Politics will always have the potential to unnerve markets in the short term, but in the long run it’s the ability of companies to generate cash that matters. The global economy remains in good shape and most companies are growing their profits and cash flows.

Companies that are on the wrong side of technological change are the notable exception and we have positioned our portfolios as best we can to avoid these situations.

Over the last month the FAANG stocks (Facebook, Apple, Amazon, Netflix, and Alphabet's Google – none of which we hold in the fund because they are US listed) have declined by 8% on average, in the wake of Facebook’s data privacy issues. However it’s important to put these moves into perspective. Over the last year they have gained 38% and over 5 years they’re up 460%.

What might seem important in the short term often pales into insignificance when viewed from a long term perspective. We will continue to focus on the business results of companies we own rather than speculate on political, stock market and economic manoeuvres.

Fund performance

The HL Select UK Growth Shares fund had a decent month, delivering a 0.1% gain compared with a 1.8% decline for the FTSE All Share. This resilience was in large part down to excellent full-year results from Burford Capital. We review these results below, as well as other contributors during the month. However, this is a very short period of time and past performance is not a guide to future returns.

Biggest positive contributors

Contribution to fund (%) Total return (%)
Burford Capital 1.5 28.1
Sanne Group 0.5 10.9
Burberry Group 0.4 10.6
Unilever 0.2 6.0
Bunzl 0.2 7.2
Reckitt Benckiser 0.2 4.5

Past performance is not a guide to the future. Source: Bloomberg 01/03/2018 – 31/03/2018

Burford Capital added 1.5% to the fund’s performance in March alone, after releasing stellar full year results (you can read more here). We continue to like the company’s long term prospects and it remains our largest holding. However, we chose to trim our holding during the month so as to keep the position around 5% of the fund.

The day after completing this sale Burford’s management announced a share placing to dispose of a third of their shareholding. The placing was at a discount to the prevailing share price so the stock price fell, but even after this sale Burford’s management retain a significant stake in the company, meaning their interests are well aligned with our own.

Sanne Group reported an encouraging set of full year results with revenues and underlying profits increasing by over 75%, driven mainly by recent acquisitions. A well thought-through and disciplined acquisition strategy can be a very effective way of accelerating growth, but buy the wrong business or pay too much and you risk destroying value.

The evidence to date suggests Sanne has bought well and we’re encouraged that recent acquisitions appear to have bedded in nicely. Overall the business seems in good shape. We believe organic growth prospects are strong and the opportunity for Sanne to further consolidate its markets is substantial.

Burberry rose after the group announced it has appointed Riccardo Tisci as its new Chief Creative Officer. Tisci joins Burberry after more than a decade at Givenchy, where he was credited with reinvigorating the brand.

Having been rather weak in the last 6 months, our consumer goods names had a better month. Unilever announced that it intends to combine to form a single legal entity in the Netherlands. This could see it removed from the UK’s FTSE 100 index but should better enable the group to make acquisitions and disposals, which we welcome.

RB rallied after discussions to acquire Pfizer’s Consumer Healthcare business ended. We are pleased to see RB’s management exercise such discipline. Hopefully, management can now concentrate on reducing leverage and improving the performance of the recently acquired Mead Johnson brands.

Biggest negative contributors

Contribution to fund (%) Total return (%)
Just Eat -0.8 -20.4
Medica -0.4 -20.9
Sage Group -0.3 -7.7
Close Brothers -0.2 -7.2
Compass Group -0.2 -5.9

Past performance is not a guide to the future. Source: Bloomberg 01/03/2018 – 31/03/2018

Just Eat weakened following an announcement of excellent results, offset by a decision to invest in providing delivery services on behalf of branded restaurant groups such as KFC and Burger King. We suspect the wider sell-off in the US tech sector also contributed to this weak performance. The finer details concerning the expansion of its delivery operations will be outlined in a Capital Markets Day in June, which we will be attending.

Medica also weakened following its full year results which showed revenues growing by 18%. The group had previously warned that these results would be slightly below market expectations, but there were no further negative or positive surprises. Encouragingly, 2018 is said to have started well and Medica expects to grow revenues by a double-digit percentage. We have added to our holding.

Close Brothers fell despite reporting mid-single digit growth in profits and dividends at the half year stage. Impairments continue to run at very low levels. At some point more people will start defaulting on their loans, but the strength of the group’s balance sheet and margins means we think it ought to be well positioned to withstand this. In our view, recent weakness in the shares is unjustified so we have added to our position.

There was no news concerning Sage or Compass.

Outlook

Currency is likely to present a headwind for international earners in 2018, following the recent strengthening of sterling. That aside, we see plenty to be encouraged by. The vast majority of our companies are growing profits and dividends, and are quietly confident of making further progress in 2018 and beyond.

Annual percentage growth
31/03/2013 -
31/03/2014
31/03/2014 -
31/03/2015
31/03/2015 -
31/03/2016
31/03/2016 -
31/03/2017
31/03/2017 -
31/03/2018
FTSE All-Share 8.8% 6.6% -3.9% 22.0% 1.2%
HL Select UK Growth Shares n/a* n/a* n/a* n/a* 6.14%

Past performance is not a guide to the future. Source: Lipper IM to 31/03/2018

*Full year performance data not available

Please note the author or his connected parties hold shares in Sanne Group and Reckitt Benckiser.

View portfolio breakdown

More about HL Select UK Growth Shares

Read more blog articles

Important - This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research for more information. Unless otherwise stated performance figures are from Bloomberg and estimates, including prospective yields, are a consensus of analyst forecasts from Bloomberg. They are not a reliable indicator of future performance. Yields are variable and not guaranteed.